Pro Medicus Valuation Multiples

Discover Pro Medicus' revenue and EBITDA valuation multiples and investment history, alongside public comparables like United Imaging, ICON plc, Revvity, Glaukos and more.

Pro Medicus Overview

About Pro Medicus

Pro Medicus is a healthcare IT company specializing in radiology imaging software. Its main product, Visage 7, is a clinical desktop application that radiologists use to view, enhance, and manipulate images from any device and make a diagnosis. Its main customers are US private academic hospitals. In fiscal 2025, Pro Medicus earned 90% of revenue in North America, 8% from Australia, and the remaining 2% in Europe.


Founded

1983

HQ

Australia

Employees

132

Financials (LTM)

Revenue: $196M
EBITDA: $159M

EV

$13B

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Pro Medicus Financials

Pro Medicus reported last 12-month revenue of $196M and EBITDA of $159M.

In the same LTM period, Pro Medicus generated $196M in gross profit, $159M in EBITDA, and $109M in net income.

Revenue (LTM)


Pro Medicus P&L

In the most recent fiscal year, Pro Medicus reported revenue of $187M and EBITDA of $269M.

Pro Medicus is profitable as of last fiscal year, with gross margin of 100%, EBITDA margin of 144%, and net margin of 101%.

See analyst estimates for Pro Medicus
LTMLast FY202320242025202620272028
Revenue$196M$187M$101M$133M$169M
Gross Profit$196M$187M$101M$132M$168M
Gross Margin100%100%100%100%100%
EBITDA$159M$269M$75M$101M$133M
EBITDA Margin81%144%74%76%79%
EBIT Margin78%75%68%72%76%
Net Profit$109M$190M$51M$70M$92M
Net Margin56%101%50%53%55%
Net Debt-($153M)---

Financial data powered by Morningstar, Inc.

Pro Medicus Stock Performance

Pro Medicus has current market cap of $13B, and enterprise value of $13B.

Market Cap Evolution


Pro Medicus' stock price is $123.17.

Pro Medicus share price decreased by 4.2% in the last 30 days, and by 39.3% in the last year.

Pro Medicus has an EPS (earnings per share) of $1.81.

See more trading valuation data for Pro Medicus
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$13B$13B-2.4%-4.2%-12.0%-39.3%$1.81

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Pro Medicus Valuation Multiples

Pro Medicus trades at 64.8x EV/Revenue multiple, and 80.1x EV/EBITDA.

See NTM and 2027E valuation multiples for Pro Medicus

EV / Revenue (LTM)


Pro Medicus Financial Valuation Multiples

As of September 3, 2026, Pro Medicus has market cap of $13B and EV of $13B.

Pro Medicus has a P/E ratio of 117.8x.

LTMLast FY202320242025202620272028
EV/Revenue64.8x67.9x125.3x95.8x75.3x
EV/EBITDA80.1x47.2x168.8x125.5x95.2x
EV/EBIT83.1x90.6x183.0x132.9x98.7x
EV/Gross Profit64.8x68.0x125.6x95.9x75.4x
P/E117.8x67.9xn/m183.6x139.4x
EV/FCF132.0x149.5xn/m200.0x153.6x

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Pro Medicus Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Pro Medicus Margins & Growth Rates

Pro Medicus grew revenue by 30% but EBITDA decreased by 29% in the last fiscal year.

In the most recent fiscal year, Pro Medicus reported gross margin of 100%, EBITDA margin of 144%, and net margin of 101%.

See estimated margins and future growth rates for Pro Medicus

Pro Medicus Margins

Last FY202420252026202720282029
Gross Margin100%100%100%100%
EBITDA Margin144%76%79%107%
EBIT Margin75%72%76%76%
Net Margin101%53%55%76%
FCF Margin45%48%49%51%

Pro Medicus Growth Rates

FY+1/FY23/2424/2525/2626/2727/2828/29
Revenue Growth30%31%27%27%
Gross Profit Growth30%31%27%28%
EBITDA Growth(29%)34%32%73%
EBIT Growth32%38%35%26%
Net Profit Growth(27%)38%32%78%
FCF Growth56%36%30%32%

Data powered by FactSet, Inc. and Morningstar, Inc.

Pro Medicus Operational KPIs

Pro Medicus' revenue per employee in the last FY averaged $1.4M, while opex per employee averaged $0.4M for the same period.

Pro Medicus' Rule of 40 is 135% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Pro Medicus' Rule of X is 176% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

Access forward-looking KPIs for Pro Medicus
LTMLast FY202320242025202620272028
Rule of 40110%135%---
Bessemer Rule of X154%176%---
Revenue per Employee-$1.4M---
Opex per Employee-$0.4M---
S&M Expenses to Revenue10%1%2%2%6%
G&A Expenses to Revenue13%13%19%18%13%
Opex to Revenue-25%31%28%23%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

Pro Medicus Competitors

Pro Medicus competitors include United Imaging, ICON plc, Revvity, Glaukos, bioMérieux, Qiagen, M3 Inc., Sonic Healthcare, Lantheus Holdings and Exact Sciences.

Most Pro Medicus public comparables operate across Healthcare Software, Medical Imaging & Diagnostics, B2B SaaS, HealthTech and Vertical SaaS.

EV/RevenueEV/EBITDA
Last FYLTM2027ELast FYLTM2027E
United Imaging5.7x5.1x32.0x28.2x
ICON plc1.8x1.8x18.2x10.7x
Revvity5.9x5.9x23.0x19.1x
Glaukos20.5x16.5x(66.4x)204.0x
bioMérieux2.1x2.1x10.2x8.7x
Qiagen4.8x4.7x15.3x12.8x
M3 Inc.3.1x2.9x14.7x11.3x
Sonic Healthcare1.5x1.3x8.5x7.5x

This data is available for Pro users. Sign up to see all Pro Medicus competitors and their valuation data.

Start Free Trial

Investments by Pro Medicus

Pro Medicus has invested in 1 company to date.

Latest investment by Pro Medicus was on August 17th 2026. Pro Medicus invested in Echo IQ in their Undisclosed stage round.

See VC round multiples

Latest Investments by Pro Medicus

Echo IQ
Description
Echo IQ Ltd is an Australian medical technology company focused on improving decision-making in cardiology. Its proprietary EchoSolv platform leverages AI-driven analysis of echocardiographic data to help clinicians detect Aortic Stenosis (AS) and other conditions with greater accuracy and efficiency. The company is focused on expanding its strategic partnerships, progressing regulatory pathways, and completing successful deployments of its technology in the USA healthcare market to establish its position in AI-enabled cardiovascular care.
HQ CountryAustralia
HQ City
-
Deal Date17 Aug 2026
RoundUndisclosed stage
Raisedundisclosed
InvestorsPro Medicus
Valuationundisclosed
EV/Revenue
EV/EBITDA

This data is available for Pro users. Sign up to see all Pro Medicus investments and their VC round multiples.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Pro Medicus

When was Pro Medicus founded?Pro Medicus was founded in 1983.
Where is Pro Medicus headquartered?Pro Medicus is headquartered in Australia.
How many employees does Pro Medicus have?As of today, Pro Medicus has over 132 employees.
Who is the CEO of Pro Medicus?Pro Medicus' CEO is Sam Aaron Hupert.
Is Pro Medicus publicly listed?Yes, Pro Medicus is a public company listed on Australian Securities Exchange.
What is the stock symbol of Pro Medicus?Pro Medicus trades under PME ticker.
When did Pro Medicus go public?Pro Medicus went public in 2000.
Who are competitors of Pro Medicus?Pro Medicus main competitors include United Imaging, ICON plc, Revvity, Glaukos, bioMérieux, Qiagen, M3 Inc., Sonic Healthcare, Lantheus Holdings, Exact Sciences.
What is the current market cap of Pro Medicus?Pro Medicus' current market cap is $13B.
What is the current revenue of Pro Medicus?Pro Medicus' last 12 months revenue is $196M.
What is the current revenue growth of Pro Medicus?Pro Medicus revenue growth (NTM/LTM) is 29%.
What is the current EV/Revenue multiple of Pro Medicus?Current revenue multiple of Pro Medicus is 64.8x.
What is the current EBITDA of Pro Medicus?Pro Medicus' last 12 months EBITDA is $159M.
What is Pro Medicus' EBITDA margin?Pro Medicus' last 12 months EBITDA margin is 81%.
What is the current EV/EBITDA multiple of Pro Medicus?Current EBITDA multiple of Pro Medicus is 80.1x.
What is the current FCF of Pro Medicus?Pro Medicus' last 12 months FCF is $96M.
What is Pro Medicus' FCF margin?Pro Medicus' last 12 months FCF margin is 49%.
What is the current EV/FCF multiple of Pro Medicus?Current FCF multiple of Pro Medicus is 132.0x.
How many companies Pro Medicus has acquired to date?Pro Medicus hasn't acquired any companies yet (or none have been disclosed publicly).
In how many companies Pro Medicus has invested to date?As of September 2026, Pro Medicus has invested in 1 company.
What was the last Pro Medicus investment?On 17th August 2026 Pro Medicus invested in Echo IQ, participating in a Undisclosed stage round.
In what companies Pro Medicus invested in?Pro Medicus invested in Echo IQ.

See public comps similar to Pro Medicus

Lists including Pro Medicus

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial